Biomimetic Nanocarriers of Pro-Resolving Lipid Mediators for Resolution of Inflammation in Atherosclerosis

被引:3
作者
Anghelache, Maria [1 ]
Voicu, Geanina [1 ]
Deleanu, Mariana [2 ]
Turtoi, Mihaela [1 ]
Safciuc, Florentina [1 ]
Anton, Ruxandra [1 ]
Boteanu, Delia [1 ]
Fenyo, Ioana Madalina [3 ]
Manduteanu, Ileana [1 ]
Simionescu, Maya [1 ]
Calin, Manuela [1 ]
机构
[1] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Med & Pharmaceut Bionanotechnol Lab, Bucharest 050568, Romania
[2] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Liquid & Gas Chromatog Lab, Bucharest 050568, Romania
[3] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Gene Regulat & Mol Therapies Lab, Bucharest 050568, Romania
关键词
atherosclerosis; biomimetic nanoparticles; endothelium; inflammation resolution; macrophages; specialized pro-resolving lipid mediators (SPMs); LONG-CHAIN OMEGA-3-FATTY-ACIDS; SMOOTH-MUSCLE-CELLS; ACTIVATED ENDOTHELIUM; NANOPARTICLES; PEPTIDES; METAANALYSIS; EXPRESSION; LIPOSOMES; DELIVERY; SIGNALS;
D O I
10.1002/adhm.202302238
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Atherosclerosis (ATH) is a systemic disease characterized by a chronic inflammatory process and lipid deposition in the arterial walls. The chronic inflammation within ATH lesions results, at least in part, from the failed resolution of inflammation. This process is controlled actively by specialized pro-resolving lipid mediators (SPMs), namely lipoxins, resolvins, protectins, and maresins. Herein, biomimetic nanocarriers are produced comprising a cocktail of SPMs-loaded lipid nanoemulsions (LN) covered with macrophage membranes (Bio-LN/SPMs). Bio-LN/SPMs retain on their surface the macrophage receptors involved in cellular interactions and the "marker of self" CD47, which impede their recognition and uptake by other macrophages. The binding of Bio-LN/SPMs to the surface of endothelial cells (EC) and smooth muscle cells (SMC) is facilitated by the receptors on the macrophage membranes and partly by SPMs receptors. In addition, Bio-LN/SPMs prove functional by reducing monocyte adhesion and transmigration to/through activated EC and by stimulating macrophage phagocytic activity. After intravenous administration, Bio-LN/SPMs accumulate in the aorta of ApoE-deficient mice at the level of atherosclerotic lesions. Also, the safety assessment testing reveals no side effects or immunotoxicity of Bio-LN/SPMs. Thus, the newly developed Bio-LN/SPMs represent a reliable targeted nanomedicine for the resolution of inflammation in atherosclerosis. Biomimetic nanocarriers of specialized pro-resolving lipid mediators (Bio-LN/SPMs) are developed for the inflammation resolution of atherosclerosis. Bio-LN/SPMs bind to endothelial and smooth muscle cells rather than to macrophages, impede monocyte adhesion/transmigration to/through activated endothelial cells, and enhance the phagocytic activity of macrophages. Moreover, they accumulate in the atherosclerotic plaque of ApoE-deficient mice and are safe for in vivo administration.image
引用
收藏
页数:20
相关论文
共 54 条
  • [1] A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk
    Alexander, Dominik D.
    Miller, Paige E.
    Van Elswyk, Mary E.
    Kuratko, Connye N.
    Bylsma, Lauren C.
    [J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (01) : 15 - 29
  • [2] Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions
    Arita, Makoto
    Oh, Sungwhan F.
    Chonan, Tomomichi
    Hong, Song
    Elangovan, Siva
    Sun, Yee-Ping
    Uddin, Jasim
    Petasis, Nicos A.
    Serhan, Charles N.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) : 22847 - 22854
  • [3] CCL5 Promotes Resolution-Phase Macrophage Reprogramming in Concert with the Atypical Chemokine Receptor D6 and Apoptotic Polymorphonuclear Cells
    Aswad, Miran
    Assi, Simaan
    Schif-Zuck, Sagie
    Ariel, Amiram
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 199 (04) : 1393 - 1404
  • [4] CD47 functions as a molecular switch for erythrocyte phagocytosis
    Burger, Patrick
    Hilarius-Stokman, Petra
    de Korte, Dirk
    van den Berg, Timo K.
    van Bruggen, Robin
    [J]. BLOOD, 2012, 119 (23) : 5512 - 5521
  • [5] Calin M., 2016, ARTERIAL REVASCULARI, P341
  • [6] Emerging Nanocarriers-based Approaches to Diagnose and Reduce Vascular Inflammation in Atherosclerosis
    Calin, Manuela
    Manduteanu, Ileana
    [J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24 (06) : 550 - 567
  • [7] VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes
    Calin, Manuela
    Stan, Daniela
    Schlesinger, Martin
    Simion, Viorel
    Deleanu, Mariana
    Constantinescu, Cristina Ana
    Gan, Ana-Maria
    Pirvulescu, Monica Madalina
    Butoi, Elena
    Manduteanu, Ileana
    Bota, Marian
    Enachescu, Marius
    Borsig, Lubor
    Bendas, Gerd
    Simionescu, Maya
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 89 : 18 - 29
  • [8] Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages
    Croasdell, Amanda
    Thatcher, Thomas H.
    Kottmann, R. Matthew
    Colas, Romain A.
    Dalli, Jesmond
    Serhan, Charles N.
    Sime, Patricia J.
    Phipps, Richard P.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 309 (08) : L888 - L901
  • [9] Proresolving and Tissue-Protective Actions of Annexin A1-Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor
    Dalli, Jesmond
    Consalvo, Angelo P.
    Ray, Vicki
    Di Filippo, Clara
    D'Amico, Michele
    Mehta, Nozer
    Perretti, Mauro
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 190 (12) : 6478 - 6487
  • [10] Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype?
    Fredman, Gabrielle
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10